Animal Healthcare Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

Animal healthcare has turned its focus area by the animal medicine industry because of increase in animal disease, vaccination, animal adoption and livestock. The global animal healthcare market is expected to gain major traction, on the backdrop of increasing pet adoption and high consumption of milk and meat. There is an increase in adoption of western culture and dynamic lifestyle in emerging countries such as India and China, which in turn has increased the pet adoption that is expected to favor the rise in growth for animal healthcare market. Pets are adopted by people all over the world for psychological and therapeutic benefits. An increase in new animal diseases such as white nose syndrome and anthrax has created opportunities in the animal healthcare market. Globally, Australia holds the leading position in pet ownership. According to the Australian Veterinary Association, there were around 4.2 million dogs and 3.3 million cats accounting for 39% and 29% market share respectively.

Get a trending sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/550

Animal healthcare market taxonomy

By Animal Type

  • Livestock Animal

  • Companion Animal

By Product Type

  • Vaccination

  • Pharmaceuticals

  • Feed Additives

By Disease Type

  • Bacterial Disease

  • Fungal Disease

  • Genetic Disease

  • Viral Disease

Pet adoption and increase in livestock fuels the growth of animal healthcare market

According to the Animal Health Institute, in the U.S., on an average, the world spends around one fortieth amount to human medicine as compared with animal medicines every year. That investment covers animal health innovations for 24 billion chickens, 750 million swine, 500 million dogs, 400 million cats and 1 billion cattle and sheep. According to Animal Health Institute, companies yearly invest around 10-12% of their sales in innovations for animal health. Scientists have developed various medicines which result in improvement, prevention, and treatment of animal diseases such as flea and tick infestation, rabies, Lyme disease, leukemia. Animal medicines are important in food safety as it accounts for production animal as well. According to the American Society for the Prevention of Cruelty to Animals, in U.S., approximately 3.2 million shelter animals adopted each year, which includes 1.6 million dogs and 1.6 million cats. According to American Pet Product Association, in U.S. from 2015 to 2016, 34% dogs are purchased from breeders at the same time 23% of dogs and 31% of cats are obtained from the animal shelter. Globally the adoption of pets has increased over a period of time and demand for meat and milk also has increased to support the growing population which is expected to fuel the animal healthcare market in the near future.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/550

Developed regions are major growth engines of animal healthcare market

Globally the market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. According to American Pet Product Association, during 2013-2014 North America is the leading market and it contributes around 68% owning the pet population has triple in from 2009 to 2014 in North America followed by Europe with a population of pets around 62 million and Asia Pacific due to the adoption of western lifestyle and increase in animal adoption. North America and Europe will be the largest market of vaccine and pharmaceuticals. Asia-Pacific will be the largest market for feed additives. In Asia Pacific, It is expected that pharmaceutical and vaccine segment will grow at a faster rate due to increased animal adoption and increased demand of meat and milk. According to IIPTF, in India 600,000 pets are adopted every year.

Key players of animal healthcare market

There are various animal healthcare market players are present all over the world. Animal healthcare industry has seen some major merger and acquisitions to develop new drugs. In 2016, Sanofi and Boehringer Ingelheim merger have taken place to develop new and improved drugs for animal healthcare. Some of the key market players of animal healthcare market includes Zoetis, Eli Lilly & Co., Novartis, Bayer Healthcare, Ceva Sante Animale, Evonik Industries AG, and ADM Alliance Nutrition.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Advertisements

Nebulizers Market – Global Industry Insights and Forecast till 2025

Nebulizers are drug delivery devices that are used to administer medicines in the form of a mist inhaled into the lungs. This drug delivery method helps in the administration of drugs such as corticosteroids, bronchodilators and anti-inflammatory medications. Nebulizers are mainly used for patients suffering from asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and other respiratory diseases or disorders. It is much comfortable to use than other forms of ingested medicines, as it targets the respiratory area directly, thus reducing side effects and harm to other body organs and cells. Nebulizers are especially used for delivery of drug to breathing passages, reduce bulging of mucous membrane, to reduce irritation caused by pollutants and activate and thin out discharge. These devices are specially developed for adults and children who are not able to handle inhalers.

Get a trending sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/545

The use of nebulizer depends on the illness for which it is designed to treat. Various considerations to be taken care of while using a nebulizer are as follows:

  • The appropriate method of using the nebulizer

  • Ways to keep the nebulizer clean for maximum safety and effectiveness

Nebulizers Market taxonomy:

On the basis of product type, the nebulizers market is classified into:

  • Ultrasonic

  • Pneumatic

  • Mesh

Ultrasonic nebulizers include portable and standalone nebulizers.

Pneumatic nebulizers are further classified into:

  • Breath Actuated nebulizers

  • Vented nebulizers

Also, mesh nebulizers are also further classified into:

  • Static type nebulizers

  • Vibrating type nebulizers

Pneumatic nebulizers hold the major share in nebulizers market due to their ease of handling, efficient design and low cost.

On the basis of end user, the nebulizers market is classified into:

  • Hospitals

  • Clinics

  • Ambulatory Surgical Centers

  • Home Care Settings

Product innovation driving the preference for nebulizers in treating respiratory conditions

The advanced nebulizers that features aerosol drug delivery technology with minimal drug wastage is expected to drive the nebulizers market growth. Patients play a vigorous role in supervising their diseases by choosing for devices that assist them in diagnosis and treatment at the comfort of their own homes. This shift in patient preferences will strengthen the global nebulizer market growth scenario in the near future. Also the rise in respiratory cases form a major factor. According to World Health Organization (WHO), around 15.7 million people were reported with Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2016 which showed a significant increase of 6.4% from 2015.

Nebulizers are also for a variety of diagnostic procedures among which the principal one is in diagnosis of lung function and bronchial activities. This has also added to the rise in demand for nebulizers in the market by the professionals for clinical use and monitoring of various associated respiratory disorders.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/545

Medical reimbursement supporting the North America nebulizer market growth

There are guidelines laid for nebulizers which facilitates its proper usage. The Centers for Medicare & Medicaid Services, and United HealthCare Services, Inc. have defined guidelines for the proper usage of nebulizers in different respiratory issues. In addition to that there are various reimbursement policies that fuel the growth of the market, for instance, policies by Medicaid & Healthcare Partnership in 2012 helped in the easy purchase of nebulizers. Under Hawaii Medical Service Association, in 2014, several cover plans were made for the easy purchases of small volume and large volume nebulizers.

Also, there exists a rental market for nebulizers that assists the usage of these devices in home care settings.

Since nebulization is a spraying technique, therefore the dispersion and wastage of the drug during delivery to the respiratory tract is one of the major restraint for the growth of nebulizers market. Moreover, low consumer switching cost and availability of alternative therapies increases the threat of substitute products.

By geography, North America holds the major share in the global nebulizers market because of the availability of reimbursement and increasing incidence of respiratory diseases.

Key players in the global nebulizers market are GE Healthcare Ltd, Agilent Technologies, GF Health Products, Philips Healthcare CareFusion Corporation, PARI Respiratory Equipment, Covidien plc and Omron Healthcare Co. The players are undertaking various clinical trials and development activities in an endeavor to improve therapeutic effect of the drug. Theravance Biopharma and Mylan announced the initiation of phase 3 studies of revefenacin at the American Thoracic Society (ATS) International Conference in 2017. Revefenacin is a once-daily long acting muscarinic antagonist (LAMA) nebulized therapy. Development of such drugs intended to be delivered via nebulization will also support propelling the growth for nebulizers market. Also Vectura received FDA approval to start testing a smart technology of nebulizers to improve asthma therapies in children.

About Coherent Market Insights:

AnchorCoherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

AnchorContact Us:

AnchorMr.Shah

AnchorCoherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

AnchorTel: +1–206–701–6702

AnchorE-mail:sales@coherentmarketinsights.com

AnchorWebsite:https://www.coherentmarketinsights.com

Sleep Apnea Devices Market — Global Industry Insights and Forecast till 2025

Sleep apnea is a chronic respiratory sleep disorder that is commonly characterized by disruption of breathing while sleeping. This is characterized by conditions such as shallow periods of breathing or occurrence of breaks and pauses during sleep. The duration pauses can be for a few seconds or can last for several minutes. These disruptive events can occur multiple times during the night. People with loud snoring habits are most vulnerable to sleep apnea. Resumption of breathing after these pauses are mostly followed by choking or snorting sounds. Most people remain undiagnosed of sleep apnea, as it occurs during the night and is difficult to be detected during routine hospital visits. Apnea essentially is the squeezing of air that passes the blockage, while breathing and results in loud snoring. These blockages are mostly encountered in overweight and obese people. People suffering from diabetes are more likely to be victims of sleep apnea. Three major types of sleep apnea are obstructive sleep apnea (OSA), central sleep apnea (CSA) and mixed sleep apnea, which is a combination of the two. Obstructive sleep apnea is the most commonly found form of sleep apnea in which the breathing is interrupted by blockage of airflow.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/414

Apart from obesity, various factors such as smoking, hereditary existence, menopause, consumption of medicines with sedative effects, having long neck, alcohol consumption, and improper sleeping habits are also responsible for prevalence of this disorder. Sleep apnea is mainly encountered among the geriatric population with growing levels of obesity. Oventus Inc. suggests that OSA prevails in approximately 3% to 7% of adult men and in 2% to 5% of adult females. In addition to this, 50% of the general population are snorers indicating the fact that this population is potential buyers of the sleep apnea devices. Around 100 million people across the globe are suspected to suffer from OSA in 2014, though the majority of this population remains undiagnosed. Sleep apnea can be treated through multiple treatment options such as natural recovery by changing everyday habits and lifestyle, as well as use of sleep apnea devices such as continuous positive airway pressure (CPAP) devices or wearable forms such as mandibular advancement devices (MAD), position pillows, dental devices or tongue retaining devices. Sleep apnea can also be treated through surgical method in severe cases.

Positive Airway Pressure (PAP) devices segment to account for highest share of the global sleep apnea devices market:

The global sleep apnea devices market can be segmented on the basis of product type and end users

On the basis of product type, the global market can be segmented as:

  • Therapeutic devices – These are further sub- segmented as:

  • PAP devices

  • Facial interfaces

  • Oxygen concentrators

  • Adaptive servo- ventilation instruments

  • Airway clearance systems

  • Others

  • Diagnostic devices- These are further sub- segmented as:

  • Polysomnography (PSG) devices

  • Respiratory polygraphs

  • Single channel screening devices

  • Actigraphy systems

    On the basis of end user, the global market can be segmented as:

  • Hospitals

  • Home Care Settings

  • Sleep Laboratories

  • Others

The North American share to contribute the highest of the sleep apnea devices market

North America dominates the global sleep apnea devices market, followed by Europe and Asia Pacific respectively. High awareness among the populace and favorable reimbursement scenario make North America a key market for sleep apnea devices. Several other factors such as venture capital funding, new legislation of PAP devices and growth of funding and grants for development in manufacturing units of sleep apnea devices are prime reasons to boost market growth in several European countries.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/414

Well established presence of multiple sleep apnea treating devices results in dominance of ResMed Inc (US) on global sleep apnea devices market

The global sleep apnea devices market is prominently driven by key players such as ResMed Inc., Phillips Healthcare, Fisher and Paykel Healthcare Ltd. These companies have their products selling over several countries, prominently in US and Europe, and has established a dominance in the field of sleep apnea devices industry due to their high investments in R&D and distribution force of strong sales. Following are the other players in global sleep apnea devices market which include SomnoMed Ltd., Weinmann Medical Devices GmbH, Compumedics Ltd., Whole You Inc., BMC Medical Co. Ltd, and Braebon Medical Corporation.

ABOUT US:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Bone Marrow Transplant Market – Global Industry Insights and Forecast till 2024

Bone marrow transplant is a medical procedure to replace bone marrow damaged or destroyed by disease, infection, or chemotherapy. Bone marrow transplant procedure involves transplanting blood stem cells that travel to the bone marrow where they produce new blood cells and promote growth of new marrow. Bone marrow is the spongy, fatty tissue inside human bones, which creates the different parts of blood such as red blood cells that carry oxygen and nutrients throughout the body; white blood cells that fight infection; and platelets responsible for formation of clots. Bone marrow also contains juvenile blood forming stem cells known as hematopoietic stem cells (HSCs). The HSC found in the bone marrow constantly creates new blood cells. Bone marrow transplant replaces damaged stem cells with healthy cells. This helps the body produce optimum levels of white blood cells, platelets, or red blood cells to avoid infections, bleeding disorders, or anemia. For transplantation, healthy stem cells are procured from a compatible donor, or healthy bone marrow is extracted from a non-affected part in the patient’s body.

Get a trending sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/232

According to Centre for Disease Control (CDC), around 14.1 million people worldwide were diagnosed with cancer in 2012, leading to 8.2 million fatalities. Furthermore, around 19.3 million new cases of cancer are projected to be diagnosed by 2025. Also, prevalence of sickle cell anemia is increasing worldwide. This inadvertently would augment demand for bone marrow transplant, thereby fueling growth of the overall bone marrow transplant market.

Bone Marrow Transplant Market

On the basis of transplantation type, the global market is classified into:

    • Allogeneic Bone marrow Transplantation

    • Autologous Bone Marrow Transplantation

On the basis of the disease indication, the global market is classified into:

    • Lymphoma

    • Leukemia

    • Myeloma

    • Myelodysplasia

    • Aplastic Anemia

    • Sickle cell Anemia

    • Solid tumors

    • Thalassemia

    • Myeloproliferative Neoplasms

On the basis of the end user, the global market is classified into:

    • Multispecialty Clinics

    • Hospitals

    • Ambulatory Surgical Centers

According to Centre for Disease control and prevention (CDC), cancer is one of the most prevalent chronic diseases, with around 20.3 million cases diagnosed in 2014. The U.S government is taking initiatives to prevent and cure the disease as a result of which, large investments in this field are expected in the near future. For instance, the National Institutes of Health (NIH), an institute of the U.S. Department of Health and Human Services (HHS), is the primary federal agency for conducting and supporting medical research. It is composed of 27 Institutes and Centers, including the National Cancer Institute (NCI), and which provides leadership and financial support to researchers in the U.S. and throughout the world.

Request for table of content : https://www.coherentmarketinsights.com/insight/request-sample/232

Increasing prevalence of cancers and anemia all over the world is the major driver for the growth of global bone marrow transplant market. And also, advances in technology, improving healthcare infrastructure, emerging indications of bone marrow transplant for heart and neuronal disorders, growing investment in logistic services, increasing per capita healthcare expenditure are some other factors expected to flourish the global bone marrow transplantation market. Major challenges for global bone marrow transplant market are high cost involved in the treatment and acute dearth of bone marrow donors.

Europe would retain its dominance in the global bone marrow transplant market in the foreseeable future. This is mainly attributed to high density of bone marrow transplant centers and growing bone marrow registries in the region. Latin America is estimated to witness rapid increase in volume of bone marrow transplant industry, due to high number of potential candidates for the procedure. Asia Pacific is characterized by relatively low prevalence of bone marrow related diseases and thus would not witness rampant growth in the near future. However, owing to easy access to high quality healthcare services at relatively low costs, the region is expected to emerge as a hub for medical tourists seeking bone marrow transplant.

Key players operating in the global bone marrow transplant market include STEMCELL Technologies, Merck Millipore Corporation, Sanofi-Aventis LLC., AllCells LLC., ReachBio LLC., Conversant Bio, Cruline Human biospecime PRO, PromoCell GmbH, and Lifeline Cell Technology.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Visit our news Website: http://www.coherentnews.com

Orthodontic Supplies Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Orthodontist deals with the diagnosis, prevention, and correction of improper position of teeth and jaws. Comprehensive orthodontic treatment include dental displacement, control, and modification of facial growth with the help of aesthetic ceramic material and stainless steel brackets (braces). Clear aligners are widely used, which are made up of clear plastic. Thus, braces helps in the reconstruction of the entire face rather than focusing on teeth only.

Sports injury and road accidents needs orthodontic treatment services, which fuels the growth of the orthopedics supplies market during the forecast period.

Request a sample pdf Copy of report @ https://www.coherentmarketinsights.com/insight/request-sample/969

Global Orthodontic Supplies Market Taxonomy:

By Product type

  • Fixed Braces

  • Removable Braces

  • Adhesives

By Bracket type

  • Conventional Brackets

  • Self-ligating Brackets

  • Lingual Brackets

By Material

  • Metal/Traditional Brackets

  • Ceramic/Aesthetic Brackets

  • Archwires

    • Beta Titanium

    • Nickel Titanium

    • Stainless Steel

  • Anchorage Appliances

    • Bands and Buccal Tubes

    • Mini-screws

  • Ligatures

    • Elastomeric Ligatures

    • Wire Ligatures

High predominance of dental issues and development of advanced technology which replace surgery is expected to propel the market growth

Regent Dental Care entered into a contract with the Department of Health and Social Care (DHSC) in 2017. Regent agreed to provide orthodontic treatment services for children under the age of 18 years, which include correction of irregular teeth and jaws and improvement of face and mouth functions. This dental care services is projected to start in DHSC from October 30, 2017, expected to fuel orthodontic supplies market growth.

In 2017, Align Technology announced the first clear aligner system in advance mandibular for class II malocclusion, especially for teen and tween. The clear aligner system provide various benefit to patients such as it reconstruct teeth and jaws, as the product is a simple single-appliance solution and elastic-free correction with six free replacement aligners. This product is also an efficient treatment in terms of cost and time saving, in turn is expected to augment the growth of orthodontic supplies market in the near future.

Major factors hampering the growth of orthodontic supplies market include high cost of orthodontic treatment, limited insurance coverage, and also risk associated with orthodontic treatment. For instance, the Singapore Dental Council (SDC) took strict disciplinary action against a dentist for inaccurate orthodontic treatment in 2017. Thus, such cases may have a negative impact on the growth of orthodontic supplies market in the near future.

Ask for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/969

Increasing dental and oral health related issues is expected to fuel growth of orthodontic supplies market

According to the National Health Interview Survey (NHIS), around 47% of women compared to 42% of men and approximately 67% of adults aged over 18 years visited dental health care professionals in early 6 months of 2012. As per NHIS, around 7% of adult population lost their set of natural teeth in 2012. Increasing cases of dental related problem expected to fuel the growth of orthodontic supplies market during the forecast period.

Some of the major key player operating in the global orthodontic supplies market include 3M Company, TP Orthodontics, Inc., Align Technology Inc., Dentaurum GmbH & Co. KG, Danaher Corporation, G&H Orthodontics, Inc., Henry Schein, Inc., Rocky Mountain Orthodontics, Inc., and American Orthodontics.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
E-mail : sales@coherentmarketinsights.com

Visit our news Website: http://www.coherentnews.com

Meningitis Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Meningitis is an inflammation in the inner lining of the brain and spinal cord that results from infectious (viral, bacterial, and rarely fungal) or non-infectious (drugs, sarcoidosis etc.) factors. The swelling associated with meninges triggers symptoms such as painful headaches, fever, loss of appetite, and stiffness of the neck. Meningitis is a fatal disease and has a rapid onset of action. Meningitis can cause severe damage to the brain in almost half of the total infected population, if untreated. It can also lead to serious ailments such as mental retardation, epilepsy, and deafness. According to Meningitis Research Foundation, as of 2017, around 80% – 90% of meningitis cases are estimated to be caused by enteroviruses and the remaining 10% is estimated to be caused by herpes virus, mumps, measles, and human immune deficiency virus. The major causes of bacterial meningitis are Neisseria meningitis (causing meningococcal disease), Haemophilus influenzae type b (causing Hib disease), and Streptococcus pneumonia (causing pneumococcal disease). Prolonged exposure to these bacteria can spread the infection. In 2010, According to the Confederation of Meningitis Organizations Inc., around 50% of the bacterial meningitis cases occur in children under the age of five years and in adolescent and young adults from 15-24 year of age.

Request a sample pdf Copy of report @ www.coherentmarketinsights.com/insight/request-sample/954

Meningitis Treatment Market Taxonomy

By Causative Micro-organism

Bacterial
Viral
Fungal
By Treatment Type

Antibiotic Therapy
Adjunctive Therapy
By Vaccine Type

Meningococcal Conjugate Vaccine
Meningococcal Polysaccharide Vaccine (MPSV4)
Combination Vaccine


Innovation in technology to combat infectious diseases is expected to drive the future meningitis treatment market

Major driving factor for growth of the meningitis treatment market include the alliance of public and private sectors to increase availability of vaccine to the populace. For instance, Global Alliance for Vaccines and Immunization (GAVIs), an international organization, brings together public and private sectors with a goal to provide access to all the latest vaccines to children in the world’s poorest countries. People suffering from immune compromised diseases such as HIV, cancer, diabetes, and organ transplants are at higher risk of contracting aseptic meningitis. Additionally, advancements in diagnostics and technological platforms are attributed to augmentation of the meningitis treatment market. For instance, in 2009, venture by Cadila with a U.S.-based vaccine company – Novavax, aimed to develop and manufacture therapeutic and prophylactic vaccines to combat infectious diseases. Introduction of new vaccine with improved mechanism, and growing advancement in genetics and immunology are expected to boost growth of the meningitis treatment market. Additionally, factors such as high incidence rate with major brain injuries via road accidents are propelling growth of the market for meningitis treatment worldwide. On the contrary, stringent regulations and alternate medications are factors hindering growth of the meningitis treatment market.

Ask for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/954

On the basis of geography, the global meningitis treatment market is expected to be the most prominent in the sub-Saharan belt of African, which is also known as the meningitis belt due to higher incidence rate of meningitis C. The second highest incidence rate is recorded in India as reported by the World Health Organization (WHO), 2015. Around 12,000 cases of meningitis C and 800 deaths were recorded in Nigeria, in 2015. This indicates the rising incidence rate of meningitis, which in turn, is expected to propel growth of the meningitis treatment market in the near future.

Global Meningitis treatment market is expected to gain momentum due to high cases of acute meningitis

The key players operating in the meningitis treatment market include Biomed Pvt. Ltd, Novartis, Nuron Biotech, Pfizer, Baxter, Merck & Co., GSK, and Sanofi. The market is set to gain momentum due to current unmet needs of vaccinations and increasing incidence of meningitis globally. Joint ventures, collaborations, and investment in research and development activities by various companies are expected to boost growth of the market. For instance, to treat aseptic meningitis, Bristol-Myers Squib is focusing on development of biologics – nivolumab (Opdivo) is in phase 3, and ipilimumab in phase 2.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
E-mail : sales@coherentmarketinsights.com

Visit our news Website: http://www.coherentnews.com

Bone Growth Stimulator Market — Global Industry Insights and Forecast till 2024

Bone Growth Stimulator Market Overview:

Bone growth stimulators or BGSs are supplemental devices that are worn after a lumbar (low back) or cervical (neck) spine surgery. Bone growth stimulators can be used to assist spinal bone fuse after a failed fusion procedure. Bone growth stimulation for the cervical and lumbar spine has significant benefits after a fusion procedure. Various doctors recommend BGS for post-operative lumbar and cervical cases. A bone growth stimulator sends low intensity electrical signals to the site of fusion. These electrical signals trigger natural bone healing process of the body, which are sometimes impaired in surgery patients. The global demographic scenario is quite diverse. For instance, India is a country with more than half of the population in the youth bracket, whereas China and the U.S. have the maximum geriatric population. Bone growth stimulators have observed an implausible demand in the past few years. The early development of BGS began in the U.S. and the innovation in technology has made developed and sophisticated products to enter the market.

According to the International Osteoporosis Foundation, osteoporosis causes around 8.9 million fractures per year that is around one osteoporotic fracture every 3 seconds. Moreover, osteoporosis is expected to affect around 200 million women worldwide. Around 80%, 75%, 70% and 58% of forearm, humerus, hip and spine fractures, respectively, affects women. A fracture, especially in the spinal cord requires bone surgery. Out of these surgeries, a significant number of patients will need bone growth stimulators due to steady recovery. This in turn will drive the growth of the overall bone growth stimulator market during the forecast period.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/225

Bone growth stimulator market Taxonomy

On the basis of type of product, the global bone growth stimulator market is classified into:

Pulsed Electromagnetic Field (PEMF) Devices

Capacitive Coupling (CC) Devices

Combined Magnetic Field (CMF) Devices

Ultrasound Bone Growth Stimulators Surgical Devices

Invasive Electrical Bone Growth Stimulators

On the basis of type of application, the global market is classified into:

Trauma injury and Fractures

Spinal Fusion

Osteogenesis

Some of the factors such as rise in per capita healthcare spending, increase in personal income, and improvement in healthcare sector will boost growth of the market in bone growth stimulator, globally. Nonetheless, a variety of factors such as uncertainty about efficacy, and availability of alternative therapies may hinder the growth of the overall market.

Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/225

Increasing prevalence of vertebral fractures, especially in the geriatric population will drive the overall bone growth stimulator market

According to the International Osteoporosis Foundation, the number of vertebral fractures that are not recognized is as high 45% in North America, and 46% in Latin America. After a surgery for a vertebral fracture, there is a high risk of requiring hospitalization for another fracture in the following years. To decrease the morbidity rates in patients with a history of bone surgeries, bone growth stimulators are used extensively. As the number of cases is increasing at an alarming rate, so is the need for bone growth stimulators. This will encourage the growth of the global bone growth stimulator market in the forecast period.

As per the International Osteoporosis Foundation, white women aged 50 years are at 16% lifetime risk of occurrence of a vertebral fracture, whereas the percentage is 5 for white men. The staggering percentage of the population with risk of vertebral fracture above the age of 50 will be responsible for increased number of bone surgeries, thereby augmenting the growth of bone growth stimulators. By geography, North America is likely to dominate the bone growth stimulator industry owing to various factors such as consumer awareness about treatments related bone fracture and injury and high healthcare expenditure. Western Europe will follow North America in terms of market share. Availability of advanced public health systems and subsidies, along with high adoption of new technologies such bone growth stimulators in this region are some of the factors for this region’s high market share.

Some of the companies operating in the bone growth stimulator market in the current scenario are Orthofix International N.V., Aetna Inc., DJO LLC, Smith & Nephew, Zimmer Biomet Holdings Inc., Ossatec Benelux BV, Elizur, Bioventus LLC., Orchid Medical, IGEA S.p.A, and Verve Consulting Inc.

ABOUT US:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com